Media Update, page-97

@Stevo_1985
Unfortunately, Atomo has not confirmed any plans for Covid19 test supply for UK&I market (yet). It would be a market sensitive ann so we would know if something was being actioned - doesn't mean they may not have any plans + ongoing partner discussions...but since Atomo has the NG Biotech + AccBio respective partnerships, any such new market foray has to advised

UK&I would fall under NG Biotech's backyard (distro EuroBio Scientific covers all EU CE marked countries)...so if anything eventuates for Ab tests, might be non-exclusive arrangement with Atomo.

AccBio Ag test partnership deal gives Atomo non-exclusive rights for AU, NZ, India markets only (so far). Would need an expansion ann.

FebriDx test of course is being used/sold in UK&I to some extent - after Lumos Diagnostic's successful trials + positive health body reviews there for Covid19 screening + core antibiotic reduction aims. I would definitely think Lumos is doing what it can to expand as fast as possible (which benefits Atomo's current OEM rev; we still need a defined supply agreement with them, which should be coming in v near future)